ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
18.29
+0.27 (1.47%)
Aug 14, 2025, 1:43 PM - Market open
ArriVent BioPharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$38.25
Upside
+109.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $42 | Strong Buy | Maintains | $40 → $42 | +129.70% | Aug 12, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $33 | Strong Buy | Maintains | $40 → $33 | +80.48% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +118.76% | Jul 22, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +80.48% | Jul 10, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +75.01% | Jun 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +140.63% | Jun 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +146.10% | Jun 24, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +118.76% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +118.76% | May 14, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +102.35% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +146.10% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +113.29% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $39 | Strong Buy | Maintains | $36 → $39 | +113.29% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +96.88% | Nov 15, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +96.88% | Sep 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +113.29% | Sep 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.